Andreas Reichel is currently the VP, Head DMPK Modelling & Simulations at Bayer, where they have been since 2019. They also serve as a guest lecturer at ETH Zürich, sitem Center for Translational Medicine and Biomedical Entrepreneurship, and the PharMetrX Graduate Research Training Program. Previously, they held roles at King's College London as a post-doc and worked as a research scientist at Roche. Additionally, Reichel was the VP, Head Research Pharmacokinetics at Bayer Pharma AG from 2007 to 2019, and they co-chaired the meeting organizing committee for ISSX from 2024 to 2025. Reichel holds a Dr. rer. nat. (PhD) from Universität Leipzig and continues their academic involvement.
This person is not in the org chart
This person is not in any teams
This person is not in any offices